title: The National Birth Defects Prevention Study.
abstract: The National Birth Defects Prevention Study was designed to identify infants with major birth defects and evaluate genetic and environmental factors associated with the occurrence of birth defects. The ongoing case-control study covers an annual birth population of 482,000 and includes cases identified from birth defect surveillance registries in eight states. Infants used as controls are randomly selected from birth certificates or birth hospital records. Mothers of case and control infants are interviewed and parents are asked to collect buccal cells from themselves and their infants for DNA testing. Information gathered from the interviews and the DNA specimens will be used to study independent genetic and environmental factors and gene-environment interactions for a broad range of birth defects. As of December 2000, 7,470 cases and 3,821 controls had been ascertained in the eight states. Interviews had been completed with 70% of the eligible case and control mothers, buccal cell collection had begun in all of the study sites, and researchers were developing analysis plans for the compiled data. This study is the largest and broadest collaborative effort ever conducted among the nation's leading birth defect researchers. The unprecedented statistical power that will result from this study will enable scientists to study the epidemiology of some rare birth defects for the first time. The compiled interview data and banked DNA of approximately 35 categories of birth defects will facilitate future research as new hypotheses and improved technologies emerge.
authors.affiliation: National Center for Environmental Health, Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA.
authors.forename: P W
authors.initials: PW
authors.lastname: Yoon
authors.forename: S A
authors.initials: SA
authors.lastname: Rasmussen
authors.forename: M C
authors.initials: MC
authors.lastname: Lynberg
authors.forename: C A
authors.initials: CA
authors.lastname: Moore
authors.forename: M
authors.initials: M
authors.lastname: Anderka
authors.forename: S L
authors.initials: SL
authors.lastname: Carmichael
authors.forename: P
authors.initials: P
authors.lastname: Costa
authors.forename: C
authors.initials: C
authors.lastname: Druschel
authors.forename: C A
authors.initials: CA
authors.lastname: Hobbs
authors.forename: P A
authors.initials: PA
authors.lastname: Romitti
authors.forename: P H
authors.initials: PH
authors.lastname: Langlois
authors.forename: L D
authors.initials: LD
authors.lastname: Edmonds
mesh_terms: D016022:Case-Control Studies; D000013:Congenital Abnormalities / Q000453:epidemiology* / Q000209:etiology / Q000235:genetics / Q000517:prevention & control*; D003299:Cooperative Behavior; D003625:Data Collection; D005260:Female; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D007231:Infant, Newborn; D007407:Interviews as Topic; D018811:Maternal Exposure; D011939:Mental Recall; D009035:Mothers; D009061:Mouth Mucosa / Q000002:abnormalities / Q000166:cytology; D015997:Neonatal Screening / Q000379:methods*; D011159:Population Surveillance; D011247:Pregnancy; D011322:Primary Prevention; D012042:Registries; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D005819:Genetic Markers